Hippocampal microdialysis during spontaneous intraoperative epileptiform activity

Area of Science:

• Neuroscience
• Epilepsy Research
• Neurochemistry

Background:

• Human hippocampal epileptogenicity mechanisms, mediated by neurochemical events, require further elucidation.
• This study presents initial microdialysis (MD) data on neuroactive amino acid recovery from the human hippocampus during epilepsy.

Purpose of the Study:

• To investigate the relationship between neuroactive amino acid levels and epileptogenicity in the human hippocampus.
• To assess the recovery of glutamate, aspartate, and gamma-aminobutyric acid (GABA) using microdialysis in patients with temporal lobe epilepsy (TLE).

Main Methods:

• Microdialysis (MD) and electrocorticography (ECoG) were performed on generally anesthetized TLE patients (N=7) undergoing surgery.
• Dialysate samples were analyzed for glutamate, aspartate, and GABA using high-performance liquid chromatography.
• Hippocampal tissue was examined for sclerosis, and ECoG data was assessed for epileptiform activity (EA).

Main Results:

• Hippocampi with minimal EA showed lower mean dialysate levels of glutamate, aspartate, and GABA.
• In contrast, hippocampi with vigorous EA exhibited significantly higher dialysate levels of these amino acids.
• All patients demonstrated hippocampal sclerosis, with varying histopathological degrees.

Conclusions:

• Dialysate levels of glutamate, aspartate, and GABA in the sclerotic hippocampus correlate with the tissue's functional state.
• Lower amino acid levels indicate quiescent or minimal epileptiform activity.
• Higher amino acid levels correspond to vigorous epileptiform activity, providing insight into hippocampal epileptogenicity.